[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Pages 17554-17555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-6582]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Arthritis and Disability: Biracial Cohort Study 
of Knee and Hip Osteoarthritis, Potential Extramural Project (PEP) 
2007-R-06 and Evaluating Sustainable Delivery Systems for Arthritis 
Intervention Programs, PEP 2007-R-08

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
SEP.

    Time and Date: 12 p.m.-4 p.m., May 14, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Arthritis and Disability: Biracial 
Cohort Study of Knee and Hip Osteoarthritis,'' Potential Extramural 
Project (PEP) 2007-R-06 and ``Evaluating Sustainable Delivery 
Systems for Arthritis Intervention Programs,'' PEP 2007- R-08.
    For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., 
CDC, 1600 Clifton Road NE, Mailstop D-72, Atlanta, GA 30333, 
Telephone (404) 639-4639.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


[[Page 17555]]


    Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-6582 Filed 4-6-07; 8:45 am]
BILLING CODE 4163-18-P